HARROW HEALTH, INC. Business Finance Contracts & Agreements

68 Contracts & Agreements
Browse by Subcategory
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Underwriting Agreement between the Company and B. Riley Securities, Inc., as representative of the several underwriters named therein, dated July 18, 2023
Underwriting Agreements
HARROW HEALTH, INC.
Pharmaceuticals
NY
2023
Loan and Security Agreement dated December 14, 2022, between the Company and B. Riley Commercial Capital, LLC
Loan Agreements
HARROW HEALTH, INC.
Pharmaceuticals
2023
Second Supplemental Indenture, dated as of December 20, 2022, by and between the Company and U.S. Bank Trust Company, National Association
Indenture Agreements
HARROW HEALTH, INC.
Pharmaceuticals
2022
Notes Underwriting Agreement between the Company and B. Riley Securities, Inc., as representative of the several underwriters named therein, dated December 15, 2022
Underwriting Agreements
HARROW HEALTH, INC.
Pharmaceuticals
NY
2022
Common Stock Underwriting Agreement between the Company and B. Riley Securities, Inc. dated December 13, 2022
Underwriting Agreements
HARROW HEALTH, INC.
Pharmaceuticals
NY
2022
Asset Purchase Agreement dated December 13, 2022, between the Company and Novartis Technology, LLC and Novartis Innovative Therapies AG
Purchase Agreements
HARROW HEALTH, INC.
Pharmaceuticals
NY
2022
Second Amendment to Loan and Security Agreement, dated as of September 21, 2022, between the Company and Melt Pharmaceuticals, Inc
Loan Agreements
HARROW HEALTH, INC.
Pharmaceuticals
DE
2022
First Amendment to Loan and Security Agreement, dated as of April 8, 2022, between the Company and Melt Pharmaceuticals, Inc
Loan Agreements
HARROW HEALTH, INC.
Pharmaceuticals
DE
2022
First Amendment to Loan and Security Agreement, dated as of April 8, 2022, between the Company and Melt Pharmaceuticals, Inc
Loan Agreements
HARROW HEALTH, INC.
Pharmaceuticals
DE
2022
Asset Purchase Agreement, dated as of December 17, 2021, by and between the Company and Novartis Technology, LLC and Novartis Ophthalmics AG
Purchase Agreements
HARROW HEALTH, INC.
Pharmaceuticals
NY
2022
Basic Sale and Purchase Agreement, dated as of August 18, 2021, by and between the Company and Wakamoto Pharmaceutical Co., Ltd
Purchase Agreements
HARROW HEALTH, INC.
Pharmaceuticals
2021
Loan and Security Agreement, dated September 1, 2021, by and between the Company and Melt Pharmaceuticals, Inc
Loan Agreements
HARROW HEALTH, INC.
Pharmaceuticals
DE
2021
Underwriting Agreement, dated as of June 14, 2021, by and among the Company and B. Riley Securities, Inc., as representative of the several underwriters named therein
Underwriting Agreements
HARROW HEALTH, INC.
Pharmaceuticals
NY
2021
Securities Purchase Agreement, dated as of May 5, 2021, by and between the Company and B. Riley Securities, Inc
Purchase Agreements
HARROW HEALTH, INC.
Pharmaceuticals
DE
2021
First Supplemental Indenture, dated as of April 20, 2021, by and between the Company and U.S. Bank National Association, as Trustee
Indenture Agreements
HARROW HEALTH, INC.
Pharmaceuticals
2021
Indenture, dated as of April 20, 2021, by and between the Company and U.S. Bank National Association, as Trustee
Indenture Agreements
HARROW HEALTH, INC.
Pharmaceuticals
NY
2021
Underwriting Agreement, dated as of April 15, 2021, by and between the Company and B. Riley Securities, Inc., as representative of the several underwriters named therein
Underwriting Agreements
HARROW HEALTH, INC.
Pharmaceuticals
NY
2021
Underwriting Agreement, dated as of April 8, 2021, by and among Harrow Health, Inc., Eton Pharmaceuticals, Inc. and National Securities Corporation
Underwriting Agreements
HARROW HEALTH, INC.
Pharmaceuticals
NY
2021
Business Loan Agreement with Renasant Bank pursuant to the Paycheck Protection Program, dated April 27, 2020
Loan Agreements
HARROW HEALTH, INC.
Pharmaceuticals
2020
Loan Agreement, dated July 26, 2019, by and between Park Compounding, Inc. and Noice Rx, LLC
Loan Agreements
HARROW HEALTH, INC.
Pharmaceuticals
DE
2019
Asset Purchase Agreement, dated July 26, 2019, by and between Park Compounding, Inc. and Noice Rx, LLC
Purchase Agreements
HARROW HEALTH, INC.
Pharmaceuticals
CA
2019
Joinder and Amendment to Loan and Security Agreement, dated May 24, 2019, by and between Harrow Health, Inc., each of its wholly-owned subsidiaries and SWK Funding LLC
Loan Agreements
HARROW HEALTH, INC.
Pharmaceuticals
NY
2019
Asset Purchase Agreement dated February 1, 2019 between Harrow Health, Inc. and Elle Pharmaceuticals, Inc
Purchase Agreements
HARROW HEALTH, INC.
Pharmaceuticals
CA
2019
Asset Purchase Agreement dated February 1, 2019 between Harrow Health, Inc. and Mayfield Pharmaceuticals, Inc
Purchase Agreements
HARROW HEALTH, INC.
Pharmaceuticals
CA
2019
Asset Purchase Agreement dated December 11, 2018 between Imprimis Pharmaceuticals, Inc. and Melt Pharmaceuticals, Inc
Purchase Agreements
HARROW HEALTH, INC.
Pharmaceuticals
CA
2019
Amend and Restated Asset Purchase and License Agreement dated April 10, 2018 between Imprimis Pharmaceuticals, Inc. and Surface Pharmaceuticals, Inc
Purchase Agreements
HARROW HEALTH, INC.
Pharmaceuticals
CA
2018
Asset Purchase and License Agreement dated September 28, 2017 between Imprimis Pharmaceuticals, Inc. and Surface Pharmaceuticals, Inc
Purchase Agreements
HARROW HEALTH, INC.
Pharmaceuticals
CA
2018
LOANAND SECURITY AGREEMENT
Security Agreements
HARROW HEALTH, INC.
Pharmaceuticals
NY
2017
IMPRIMISPHARMACEUTICALS, INC. 2017INCENTIVE STOCK AND AWARDS PLAN NOTICEOF Restricted Stock Unit AWARD
Stock Agreements
HARROW HEALTH, INC.
Pharmaceuticals
CA
2017
IMPRIMISPHARMACEUTICALS, INC. 2017INCENTIVE STOCK AND AWARDS PLAN NOTICEOF RESTRICTED STOCK AWARD
Stock Agreements
HARROW HEALTH, INC.
Pharmaceuticals
CA
2017
IMPRIMISPHARMACEUTICALS, INC. 2017INCENTIVE STOCK AND AWARD PLAN FORMOF NONQUALIFIEDSTOCK OPTION AGREEMENT
Stock Agreements
HARROW HEALTH, INC.
Pharmaceuticals
DE
2017
IMPRIMISPHARMACEUTICALS, INC. 2017INCENTIVE STOCK AND AWARDS PLAN INCENTIVESTOCK OPTION AGREEMENT
Stock Agreements
HARROW HEALTH, INC.
Pharmaceuticals
DE
2017
AMENDMENTNO. 2 TO WARRANT TO PURCHASE STOCK
Warrant Agreements
HARROW HEALTH, INC.
Pharmaceuticals
2016
EXCHANGEAND DISCHARGE AGREEMENT
Exchange Agreements
HARROW HEALTH, INC.
Pharmaceuticals
2016
THIRDAMENDMENT TO LOAN AND SECURITY AGREEMENT
Loan Agreements
HARROW HEALTH, INC.
Pharmaceuticals
NY
2016
IMPRIMISPHARMACEUTICALS, INC. COMMONSTOCK PURCHASE WARRANT
Warrant Agreements
HARROW HEALTH, INC.
Pharmaceuticals
NY
2016
REGISTRATIONRIGHTS AGREEMENT
Registration Rights Agreements
HARROW HEALTH, INC.
Pharmaceuticals
NY
2016
IMPRIMISPHARMACEUTICALS, inc. 2,900,000 SHARESOF COMMON STOCK UNDERWRITINGAGREEMENT
Stock Agreements
HARROW HEALTH, INC.
Pharmaceuticals
NY
2016
AMENDMENTTO WARRANT TO PURCHASE STOCK
Warrant Agreements
HARROW HEALTH, INC.
Pharmaceuticals
2016
SECONDAMENDMENT TO LOAN AND SECURITY AGREEMENT
Loan Agreements
HARROW HEALTH, INC.
Pharmaceuticals
NY
2016